
Tirocip 50mcg Infusion
Marketer
Cipla Ltd
Salt Composition
Tirofiban (50mcg)
Overview Tirocip 50mcg Infusion
CardioGuard 50mcg infusion is an anticoagulant that inhibits the development of dangerous blood clots. It aids in preventing myocardial infarction in patients experiencing acute chest pain stemming from reduced myocardial perfusion. CardioGuard 50mcg infusion is administered under strict medical supervision. Dosage and treatment length will be determined by your physician. Continue all other prescribed medications as directed, even following this injection. Frequently reported adverse reactions include headache, hematoma, nausea, bruising, post-surgical bleeding, and gastrointestinal or urinary bleeding. Report immediately any petechiae or the presence of blood in vomit, urine, or feces. This medication requires careful consideration for certain individuals. Prior to administration, disclose any bleeding disorders, renal or hepatic impairments, breastfeeding, and all other concurrent medications to your doctor.
Primary Ingredients of Tirocip 50mcg Infusion
No information provided. Unable to rephrase.
Uses of Tirocip 50mcg Infusion
Avoiding a myocardial infarction
Major Benefits of Tirocip 50mcg Infusion:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tirocip 50mcg Infusion:
- Headache
- Nausea
- Hematoma
- Ecchymosis (discoloration of the skin resulting from bleeding underneath)
- Postoperative bleeding
- Blood in stool
- Blood in urine
How to use Tirocip 50mcg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tirocip 50mcg Infusion works:
Tirocip 50mcg infusion is an antithrombotic agent that inhibits platelet aggregation, reducing the risk of dangerous blood clot development and consequently minimizing the likelihood of a heart attack or stroke.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tirocip 50mcg Infusion may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Tirocip 50mcg Infusion during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Tirocip 50mcg Infusion to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Inapplicable, given that Tirocip 50mcg Infusion is administered solely within a hospital setting.
KidneyCAUTION
Patients with kidney impairment should receive Tirocip 50mcg Infusion with careful monitoring. Dosage modification of Tirocip 50mcg Infusion might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should receive Tirocip 50mcg Infusion cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Tirocip 50mcg Infusion; physician consultation is advised.
What if you forget to take Tirocip 50mcg Infusion :
Omit a dose of Tirocip 50mcg Infusion? Seek your physician's advice.
Facts to Know About Tirocip 50mcg Infusion
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based compounds |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | IIb/IIIa receptor antagonists |
